Can glypican-3 be a disease-specific biomarker?

Can glypican-3 be a disease-specific biomarker?

Abstract Background Glypican-3 (GPC3) is a cell surface-bound proteoglycan which has been identified as a potential biomarker candidate in hepatocellular carcinoma, lung carcinoma, severe pneumonia, and acute respiratory distress syndrome (ARDS). The aim of our review is to evaluate whether GPC3 has...

Full description

Bibliographic Details
Main Authors: Chaolei Chen, Xiaomin Huang, Zhaojian Ying, Dengmin Wu, Yani Yu, Xiangdong Wang, Chengshui Chen
Format: Article
Language:English
Published: Springer 2017-05-01
Series:Clinical and Translational Medicine
Subjects:
Glypican-3
Cancer
Biomarkers
Disease
Therapy
Online Access:http://link.springer.com/article/10.1186/s40169-017-0146-5

Internet

http://link.springer.com/article/10.1186/s40169-017-0146-5

Similar Items